Phase III Study of Docetaxel + S-1 vs. S-1 for Advanced Gastric Cancer

NCT00287768 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

628

Enrollment

OTHER

Sponsor class

Conditions

Gastric Cancer

Interventions

DRUG: docetaxel + S-1
DRUG: S-1

Sponsor

Japan Clinical Cancer Research Organization

Collaborators

[object Object]